USA - NASDAQ:DXCM - US2521311074 - Common Stock
We assign a fundamental rating of 6 out of 10 to DXCM. DXCM was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While DXCM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make DXCM a good candidate for growth investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.8% | ||
ROE | 22.21% | ||
ROIC | 14.52% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 17.22% | ||
PM (TTM) | 13.29% | ||
GM | 60.01% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.5 | ||
Debt/FCF | 4.38 | ||
Altman-Z | 5.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.52 | ||
Quick Ratio | 1.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 41.52 | ||
Fwd PE | 26.86 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 48.49 | ||
EV/EBITDA | 25.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:DXCM (10/22/2025, 2:47:10 PM)
70.58
+0.83 (+1.19%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 41.52 | ||
Fwd PE | 26.86 | ||
P/S | 6.44 | ||
P/FCF | 48.49 | ||
P/OCF | 28.02 | ||
P/B | 10.76 | ||
P/tB | 11.24 | ||
EV/EBITDA | 25.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.8% | ||
ROE | 22.21% | ||
ROCE | 18.43% | ||
ROIC | 14.52% | ||
ROICexc | 53.56% | ||
ROICexgc | 59.66% | ||
OM | 17.22% | ||
PM (TTM) | 13.29% | ||
GM | 60.01% | ||
FCFM | 13.27% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.5 | ||
Debt/FCF | 4.38 | ||
Debt/EBITDA | 1.33 | ||
Cap/Depr | 176.58% | ||
Cap/Sales | 9.69% | ||
Interest Coverage | 250 | ||
Cash Conversion | 101.12% | ||
Profit Quality | 99.88% | ||
Current Ratio | 1.52 | ||
Quick Ratio | 1.35 | ||
Altman-Z | 5.01 |